Expression Analysis has hired Raisa Lowe as director of quality assurance. Lowe will be responsible for implementing quality initiatives at the company, including continued compliance to Good Laboratory Practices, Good Clinical Practices, and compliance with the Clinical Laboratory Improvement Amendment.
Lowe previously held quality-assurance and compliance positions at Wellstat Biologics and Therapeutics, Diosynth RTP, and Compliance Quest.
Lowe holds a BS in biology from the Interamerican University of Puerto Rico and an MS in biotechnology from Johns Hopkins University.
Illumina spokesman Bill Craumer has left the company to join Isis Pharmaceuticals, he said in an e-mail last week.
Isis, located in Carlsbad, Calif., just up the coast from Illumina’s San Diego headquarters, has a technology that discovers drugs focused on RNA targets in the areas of cardiovascular, metabolic, inflammatory diseases, and cancer, according to Craumer.
He said the company plans to commercialize “an integrated biosensor system for use in disease surveillance, infectious disease research and diagnostics.”
Jens Beator has been named manager of Protagen’s newly formed protein biochips unit, the company said last week. He will now oversee commercialization of the firm’s UNIchip protein array line.
Beator previously served as director of business development for protein arrays Europe at Whatman, formerly Schleicher & Schuell BioScience. He also held positions in sales at Biometra and Thermo Shandon.